Furthermore, some studies have suggested that serum hepcidin could reflect disease activity raising its measurement as a new surrogate biomarker of RA. [3] [4] [5] [6] These studies have several drawbacks (unreliable pro-hormone quantification, small number of patients). 7 8 Therefore, we assessed the serum level of the mature form of hepcidin by ELISA (Bachem, St Helens, Merseyside, UK) in 791 individuals from the French cohort of early arthritis (ESPOIR) including 632 patients with RA fulfilling the American College of Rheumatology (ACR) -European League Against Rheumatism (EULAR) criteria at inclusion and 159 with undifferentiated arthritis in order to address whether hepcidin accurately reflects RA features, disease activity or radiographic disease progression. 9 10 Beyond expected differences between RA and undifferentiated arthritis, serum hepcidin level was higher in RA (table 1) .
Hepcidin level was positively correlated with disease activity score in 28 joints (DAS28)-erythrocyte sedimentation rate at inclusion. However, the only variable used in calculating DAS28 that was correlated with hepcidin level was erythrocyte sedimentation rate suggesting that hepcidin reflected the inflammatory state only (table 2) . The correlation with C reactive protein (CRP) level and ferritinemia but not with the Clinical Disease Activity Index supports such a conclusion. However, the positive correlation of hepcidin with Health Assessment Questionnaire score (table 2) even after adjustment on CRP using a linear regression analysis (β coefficient=0.1; p=0.038) suggests that serum hepcidin could reflect RA severity, beyond the inflammatory state. Hepcidin level (mean±SD) was increased in patients positive for rheumatoid factor (57.5±51.6 vs 46.9±43.2 ng/ml; p=0.0007) and anticyclic citrullinated peptide antibodies (58.3±52.2 vs 47.8±44.0 ng/ml, p=0.0007) but was not correlated with autoantibodies levels (table 2) .
Patients with radiographic lesions of RA on hands and feet x-rays at inclusion (n=160 on 529 with available radiographs) had hepcidin level higher than those without (62.8±50.0 vs 51.0±47.9 ng/ml, p=0.0007). Baseline hepcidin and total Sharp-van der Heijde score (SHS) at inclusion or at 1 year were correlated due to the correlation with erosion SHS (table 2) . Simple logistic regression analysis performed using logtransformed hepcidin level to remove positive skewness before analysis as continuous variables corroborated this result: log (hepcidin level) was associated with radiographic lesions at inclusion (OR (95% CI) 1.56 (1.20 to 2.02), p=0.0009). Therefore, for each 1-unit increase in log (hepcidin) (ng/ml), the risk of radiographic alterations increased by 56%. However, Conversely to other studies assessing pro-hepcidin or using another method of measurement, anaemic (n=295) and non-anaemic RA patients (n=332) exhibited no difference in hepcidin level (48.3±45.8 vs 57.5±50.6 ng/ml; p=0.42) and haemoglobin and hepcidin levels were not correlated, suggesting that role of mature hepcidin in RA-related anaemia needs further investigations. [2] [3] [4] [5] [6] In conclusion, serum hepcidin level was elevated in seropositive and erosive RA and was correlated with disease activity because of its link with other unspecific inflammatory biomarkers. Hepcidin level was not independently associated with radiographic alterations or progression and thus did not give additional information beyond the usual biomarkers of inflammation or autoantibody status. Competing interests None.
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